Skip to main content
DYAI
NASDAQ Life Sciences

Q3 Revenue Drops 61.4% to $449.1K as Dyadic Flags Going-Concern Doubt

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.35
Mkt Cap
$14.026M
52W Low
$0.33
52W High
$1.6
52W Position info
6.1% above low
Off High info
78% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

DYAI is trading near its 52-week low of $0.33 (6.1% above the low).

Summary

Q3 revenue collapsed 61.4% to $449.1K from $1.2M a year ago as grant and R&D revenue dried up; first direct product sales were immaterial. The net loss narrowed to $1.4M from $2.0M, but that was helped by a $545.5K non-cash warrant-liability gain, not operations. Cash, restricted cash and securities fell to $6.0M from $8.6M at December 31, 2025, and the company again disclosed substantial doubt about continuing as a going concern for 12 months. This lands on top of the September 25 Nasdaq deficiency notices for the $1 minimum bid price and another listing standard, with the stock at $0.35 and an already-active at-the-market program. Only $225K of expected Q4 milestone revenue from a partner's second chymosin commercial sale is on the near-term horizon; comparative preclinical study results are anticipated in Q1 2027.

At the time of this announcement, DYAI was trading at $0.35 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $14M. The 52-week trading range was $0.33 to $1.60. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

DYAI - Latest Insights

DYAI
Nov 13, 2026, 4:00 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.327
Real-time Price: $0.350 info
Change: +$0.023 (+7%) info
Market Cap: $13.101M info
DYAI
Sep 25, 2026, 5:27 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.4198
Real-time Price: $0.350 info
Change: -$0.0698 (-17%) info
Market Cap: $13.101M info
DYAI
Aug 17, 2026, 7:27 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.710
Real-time Price: $0.350 info
Change: -$0.360 (-51%) info
Market Cap: $13.101M info
DYAI
Aug 14, 2026, 9:17 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.7702
Real-time Price: $0.350 info
Change: -$0.4202 (-55%) info
Market Cap: $13.101M info
DYAI
Aug 13, 2026, 5:25 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $0.7854
Real-time Price: $0.350 info
Change: -$0.4354 (-55%) info
Market Cap: $13.101M info